Loading company…
The Speedel Group develops renin inhibitors for cardiovascular and metabolic diseases.
The Speedel Group is a biopharmaceutical company developing renin inhibitors to treat cardiovascular and metabolic diseases. It is based in Basel, Switzerland.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in